aluates Reports

$ 0.0

Automative

Global Lipid Nanoparticle CDMO Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-0U19489

BUY CHAPTERS

Global Lipid Nanoparticle CDMO Market Research Report 2025

Code: QYRE-Auto-0U19489

Report

March 2025

Pages:98

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GenScript

Creative-Biolabs

Merck

Cytiva

WuXi STA

Croda International

Waters

Precigenome

Evonik

Avanti Polar Lipids

Genevant Sciences

Nippon Fine Chemical

Lipoid

Carcell

Detai Biotechnology

MicroNano Biologics

Lipid Nanoparticle CDMO Market Size

The global market for Lipid Nanoparticle CDMO was valued at US$ 6400 million in the year 2024 and is projected to reach a revised size of US$ 13760 million by 2031, growing at a CAGR of 11.5% during the forecast period.

Lipid Nanoparticle CDMO Market

A Contract Development and Manufacturing Organization (CDMO) that specializes in the development and production of lipid nanoparticles (LNPs). LNPs are used in various biomedical applications, particularly for drug delivery systems, including RNA-based therapies like mRNA vaccines. A lipid nanoparticle CDMO provides services ranging from the formulation of lipid nanoparticles to large-scale production, ensuring quality, scalability, and compliance with regulatory standards.

North American market for Lipid Nanoparticle CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Lipid Nanoparticle CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Lipid Nanoparticle CDMO in Gene Therapy is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Lipid Nanoparticle CDMO include GenScript, Creative Biolabs, Merck, Cytiva, WuXi STA, Carcell, Croda International, Detai Biotechnology, Waters, MicroNano Biologics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Lipid Nanoparticle CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lipid Nanoparticle CDMO.

The Lipid Nanoparticle CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lipid Nanoparticle CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lipid Nanoparticle CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Lipid Nanoparticle CDMO Market Report

Report Metric	Details
Report Name	Lipid Nanoparticle CDMO Market
Accounted market size in year	US$ 6400 million
Forecasted market size in 2031	US$ 13760 million
CAGR	11.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Solid Lipid Nanoparticles Nanostructured Lipid Carriers Cationic Lipid-Nucleic Acid Complexes
Segment by Application	Gene Therapy Vaccine Development Cancer Treatment
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GenScript, Creative Biolabs, Merck, Cytiva, WuXi STA, Carcell, Croda International, Detai Biotechnology, Waters, MicroNano Biologics, Precigenome, Evonik, Avanti Polar Lipids, Genevant Sciences, Nippon Fine Chemical, Lipoid
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lipid Nanoparticle CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Lipid Nanoparticle CDMO Market growing?

Ans: The Lipid Nanoparticle CDMO Market witnessing a CAGR of 11.5% during the forecast period 2025-2031.

What is the Lipid Nanoparticle CDMO Market size in 2031?

Ans: The Lipid Nanoparticle CDMO Market size in 2031 will be US$ 13760 million.

Who are the main players in the Lipid Nanoparticle CDMO Market report?

Ans: The main players in the Lipid Nanoparticle CDMO Market are GenScript, Creative Biolabs, Merck, Cytiva, WuXi STA, Carcell, Croda International, Detai Biotechnology, Waters, MicroNano Biologics, Precigenome, Evonik, Avanti Polar Lipids, Genevant Sciences, Nippon Fine Chemical, Lipoid

What are the Application segmentation covered in the Lipid Nanoparticle CDMO Market report?

Ans: The Applications covered in the Lipid Nanoparticle CDMO Market report are Gene Therapy, Vaccine Development, Cancer Treatment

What are the Type segmentation covered in the Lipid Nanoparticle CDMO Market report?

Ans: The Types covered in the Lipid Nanoparticle CDMO Market report are Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, Cationic Lipid-Nucleic Acid Complexes

Recommended Reports

CDMO Services

Lipid Nanoparticles

Drug Delivery

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lipid Nanoparticle CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Solid Lipid Nanoparticles

1.2.3 Nanostructured Lipid Carriers

1.2.4 Cationic Lipid-Nucleic Acid Complexes

1.3 Market by Application

1.3.1 Global Lipid Nanoparticle CDMO Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Gene Therapy

1.3.3 Vaccine Development

1.3.4 Cancer Treatment

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Lipid Nanoparticle CDMO Market Perspective (2020-2031)

2.2 Global Lipid Nanoparticle CDMO Growth Trends by Region

2.2.1 Global Lipid Nanoparticle CDMO Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Lipid Nanoparticle CDMO Historic Market Size by Region (2020-2025)

2.2.3 Lipid Nanoparticle CDMO Forecasted Market Size by Region (2026-2031)

2.3 Lipid Nanoparticle CDMO Market Dynamics

2.3.1 Lipid Nanoparticle CDMO Industry Trends

2.3.2 Lipid Nanoparticle CDMO Market Drivers

2.3.3 Lipid Nanoparticle CDMO Market Challenges

2.3.4 Lipid Nanoparticle CDMO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Lipid Nanoparticle CDMO Players by Revenue

3.1.1 Global Top Lipid Nanoparticle CDMO Players by Revenue (2020-2025)

3.1.2 Global Lipid Nanoparticle CDMO Revenue Market Share by Players (2020-2025)

3.2 Global Top Lipid Nanoparticle CDMO Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Lipid Nanoparticle CDMO Revenue

3.4 Global Lipid Nanoparticle CDMO Market Concentration Ratio

3.4.1 Global Lipid Nanoparticle CDMO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lipid Nanoparticle CDMO Revenue in 2024

3.5 Global Key Players of Lipid Nanoparticle CDMO Head office and Area Served

3.6 Global Key Players of Lipid Nanoparticle CDMO, Product and Application

3.7 Global Key Players of Lipid Nanoparticle CDMO, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Lipid Nanoparticle CDMO Breakdown Data by Type

4.1 Global Lipid Nanoparticle CDMO Historic Market Size by Type (2020-2025)

4.2 Global Lipid Nanoparticle CDMO Forecasted Market Size by Type (2026-2031)

5 Lipid Nanoparticle CDMO Breakdown Data by Application

5.1 Global Lipid Nanoparticle CDMO Historic Market Size by Application (2020-2025)

5.2 Global Lipid Nanoparticle CDMO Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Lipid Nanoparticle CDMO Market Size (2020-2031)

6.2 North America Lipid Nanoparticle CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Lipid Nanoparticle CDMO Market Size by Country (2020-2025)

6.4 North America Lipid Nanoparticle CDMO Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Lipid Nanoparticle CDMO Market Size (2020-2031)

7.2 Europe Lipid Nanoparticle CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Lipid Nanoparticle CDMO Market Size by Country (2020-2025)

7.4 Europe Lipid Nanoparticle CDMO Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Lipid Nanoparticle CDMO Market Size (2020-2031)

8.2 Asia-Pacific Lipid Nanoparticle CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Lipid Nanoparticle CDMO Market Size by Region (2020-2025)

8.4 Asia-Pacific Lipid Nanoparticle CDMO Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Lipid Nanoparticle CDMO Market Size (2020-2031)

9.2 Latin America Lipid Nanoparticle CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Lipid Nanoparticle CDMO Market Size by Country (2020-2025)

9.4 Latin America Lipid Nanoparticle CDMO Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Lipid Nanoparticle CDMO Market Size (2020-2031)

10.2 Middle East & Africa Lipid Nanoparticle CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Lipid Nanoparticle CDMO Market Size by Country (2020-2025)

10.4 Middle East & Africa Lipid Nanoparticle CDMO Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GenScript

11.1.1 GenScript Company Details

11.1.2 GenScript Business Overview

11.1.3 GenScript Lipid Nanoparticle CDMO Introduction

11.1.4 GenScript Revenue in Lipid Nanoparticle CDMO Business (2020-2025)

11.1.5 GenScript Recent Development

11.2 Creative Biolabs

11.2.1 Creative Biolabs Company Details

11.2.2 Creative Biolabs Business Overview

11.2.3 Creative Biolabs Lipid Nanoparticle CDMO Introduction

11.2.4 Creative Biolabs Revenue in Lipid Nanoparticle CDMO Business (2020-2025)

11.2.5 Creative Biolabs Recent Development

11.3 Merck

11.3.1 Merck Company Details

11.3.2 Merck Business Overview

11.3.3 Merck Lipid Nanoparticle CDMO Introduction

11.3.4 Merck Revenue in Lipid Nanoparticle CDMO Business (2020-2025)

11.3.5 Merck Recent Development

11.4 Cytiva

11.4.1 Cytiva Company Details

11.4.2 Cytiva Business Overview

11.4.3 Cytiva Lipid Nanoparticle CDMO Introduction

11.4.4 Cytiva Revenue in Lipid Nanoparticle CDMO Business (2020-2025)

11.4.5 Cytiva Recent Development

11.5 WuXi STA

11.5.1 WuXi STA Company Details

11.5.2 WuXi STA Business Overview

11.5.3 WuXi STA Lipid Nanoparticle CDMO Introduction

11.5.4 WuXi STA Revenue in Lipid Nanoparticle CDMO Business (2020-2025)

11.5.5 WuXi STA Recent Development

11.6 Carcell

11.6.1 Carcell Company Details

11.6.2 Carcell Business Overview

11.6.3 Carcell Lipid Nanoparticle CDMO Introduction

11.6.4 Carcell Revenue in Lipid Nanoparticle CDMO Business (2020-2025)

11.6.5 Carcell Recent Development

11.7 Croda International

11.7.1 Croda International Company Details

11.7.2 Croda International Business Overview

11.7.3 Croda International Lipid Nanoparticle CDMO Introduction

11.7.4 Croda International Revenue in Lipid Nanoparticle CDMO Business (2020-2025)

11.7.5 Croda International Recent Development

11.8 Detai Biotechnology

11.8.1 Detai Biotechnology Company Details

11.8.2 Detai Biotechnology Business Overview

11.8.3 Detai Biotechnology Lipid Nanoparticle CDMO Introduction

11.8.4 Detai Biotechnology Revenue in Lipid Nanoparticle CDMO Business (2020-2025)

11.8.5 Detai Biotechnology Recent Development

11.9 Waters

11.9.1 Waters Company Details

11.9.2 Waters Business Overview

11.9.3 Waters Lipid Nanoparticle CDMO Introduction

11.9.4 Waters Revenue in Lipid Nanoparticle CDMO Business (2020-2025)

11.9.5 Waters Recent Development

11.10 MicroNano Biologics

11.10.1 MicroNano Biologics Company Details

11.10.2 MicroNano Biologics Business Overview

11.10.3 MicroNano Biologics Lipid Nanoparticle CDMO Introduction

11.10.4 MicroNano Biologics Revenue in Lipid Nanoparticle CDMO Business (2020-2025)

11.10.5 MicroNano Biologics Recent Development

11.11 Precigenome

11.11.1 Precigenome Company Details

11.11.2 Precigenome Business Overview

11.11.3 Precigenome Lipid Nanoparticle CDMO Introduction

11.11.4 Precigenome Revenue in Lipid Nanoparticle CDMO Business (2020-2025)

11.11.5 Precigenome Recent Development

11.12 Evonik

11.12.1 Evonik Company Details

11.12.2 Evonik Business Overview

11.12.3 Evonik Lipid Nanoparticle CDMO Introduction

11.12.4 Evonik Revenue in Lipid Nanoparticle CDMO Business (2020-2025)

11.12.5 Evonik Recent Development

11.13 Avanti Polar Lipids

11.13.1 Avanti Polar Lipids Company Details

11.13.2 Avanti Polar Lipids Business Overview

11.13.3 Avanti Polar Lipids Lipid Nanoparticle CDMO Introduction

11.13.4 Avanti Polar Lipids Revenue in Lipid Nanoparticle CDMO Business (2020-2025)

11.13.5 Avanti Polar Lipids Recent Development

11.14 Genevant Sciences

11.14.1 Genevant Sciences Company Details

11.14.2 Genevant Sciences Business Overview

11.14.3 Genevant Sciences Lipid Nanoparticle CDMO Introduction

11.14.4 Genevant Sciences Revenue in Lipid Nanoparticle CDMO Business (2020-2025)

11.14.5 Genevant Sciences Recent Development

11.15 Nippon Fine Chemical

11.15.1 Nippon Fine Chemical Company Details

11.15.2 Nippon Fine Chemical Business Overview

11.15.3 Nippon Fine Chemical Lipid Nanoparticle CDMO Introduction

11.15.4 Nippon Fine Chemical Revenue in Lipid Nanoparticle CDMO Business (2020-2025)

11.15.5 Nippon Fine Chemical Recent Development

11.16 Lipoid

11.16.1 Lipoid Company Details

11.16.2 Lipoid Business Overview

11.16.3 Lipoid Lipid Nanoparticle CDMO Introduction

11.16.4 Lipoid Revenue in Lipid Nanoparticle CDMO Business (2020-2025)

11.16.5 Lipoid Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

GenScript

Creative-Biolabs

Merck

Cytiva

WuXi STA

Croda International

Waters

Precigenome

Evonik

Avanti Polar Lipids

Genevant Sciences

Nippon Fine Chemical

Lipoid

Carcell

Detai Biotechnology

MicroNano Biologics

List of Tables

Table 1. Global Lipid Nanoparticle CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Solid Lipid Nanoparticles

Table 3. Key Players of Nanostructured Lipid Carriers

Table 4. Key Players of Cationic Lipid-Nucleic Acid Complexes

Table 5. Global Lipid Nanoparticle CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Lipid Nanoparticle CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Lipid Nanoparticle CDMO Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Lipid Nanoparticle CDMO Market Share by Region (2020-2025)

Table 9. Global Lipid Nanoparticle CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Lipid Nanoparticle CDMO Market Share by Region (2026-2031)

Table 11. Lipid Nanoparticle CDMO Market Trends

Table 12. Lipid Nanoparticle CDMO Market Drivers

Table 13. Lipid Nanoparticle CDMO Market Challenges

Table 14. Lipid Nanoparticle CDMO Market Restraints

Table 15. Global Lipid Nanoparticle CDMO Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Lipid Nanoparticle CDMO Market Share by Players (2020-2025)

Table 17. Global Top Lipid Nanoparticle CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lipid Nanoparticle CDMO as of 2024)

Table 18. Ranking of Global Top Lipid Nanoparticle CDMO Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Lipid Nanoparticle CDMO Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Lipid Nanoparticle CDMO, Headquarters and Area Served

Table 21. Global Key Players of Lipid Nanoparticle CDMO, Product and Application

Table 22. Global Key Players of Lipid Nanoparticle CDMO, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Lipid Nanoparticle CDMO Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Lipid Nanoparticle CDMO Revenue Market Share by Type (2020-2025)

Table 26. Global Lipid Nanoparticle CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Lipid Nanoparticle CDMO Revenue Market Share by Type (2026-2031)

Table 28. Global Lipid Nanoparticle CDMO Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Lipid Nanoparticle CDMO Revenue Market Share by Application (2020-2025)

Table 30. Global Lipid Nanoparticle CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Lipid Nanoparticle CDMO Revenue Market Share by Application (2026-2031)

Table 32. North America Lipid Nanoparticle CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Lipid Nanoparticle CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Lipid Nanoparticle CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Lipid Nanoparticle CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Lipid Nanoparticle CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Lipid Nanoparticle CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Lipid Nanoparticle CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Lipid Nanoparticle CDMO Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Lipid Nanoparticle CDMO Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Lipid Nanoparticle CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Lipid Nanoparticle CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Lipid Nanoparticle CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Lipid Nanoparticle CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Lipid Nanoparticle CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Lipid Nanoparticle CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 47. GenScript Company Details

Table 48. GenScript Business Overview

Table 49. GenScript Lipid Nanoparticle CDMO Product

Table 50. GenScript Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)

Table 51. GenScript Recent Development

Table 52. Creative Biolabs Company Details

Table 53. Creative Biolabs Business Overview

Table 54. Creative Biolabs Lipid Nanoparticle CDMO Product

Table 55. Creative Biolabs Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)

Table 56. Creative Biolabs Recent Development

Table 57. Merck Company Details

Table 58. Merck Business Overview

Table 59. Merck Lipid Nanoparticle CDMO Product

Table 60. Merck Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)

Table 61. Merck Recent Development

Table 62. Cytiva Company Details

Table 63. Cytiva Business Overview

Table 64. Cytiva Lipid Nanoparticle CDMO Product

Table 65. Cytiva Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)

Table 66. Cytiva Recent Development

Table 67. WuXi STA Company Details

Table 68. WuXi STA Business Overview

Table 69. WuXi STA Lipid Nanoparticle CDMO Product

Table 70. WuXi STA Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)

Table 71. WuXi STA Recent Development

Table 72. Carcell Company Details

Table 73. Carcell Business Overview

Table 74. Carcell Lipid Nanoparticle CDMO Product

Table 75. Carcell Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)

Table 76. Carcell Recent Development

Table 77. Croda International Company Details

Table 78. Croda International Business Overview

Table 79. Croda International Lipid Nanoparticle CDMO Product

Table 80. Croda International Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)

Table 81. Croda International Recent Development

Table 82. Detai Biotechnology Company Details

Table 83. Detai Biotechnology Business Overview

Table 84. Detai Biotechnology Lipid Nanoparticle CDMO Product

Table 85. Detai Biotechnology Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)

Table 86. Detai Biotechnology Recent Development

Table 87. Waters Company Details

Table 88. Waters Business Overview

Table 89. Waters Lipid Nanoparticle CDMO Product

Table 90. Waters Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)

Table 91. Waters Recent Development

Table 92. MicroNano Biologics Company Details

Table 93. MicroNano Biologics Business Overview

Table 94. MicroNano Biologics Lipid Nanoparticle CDMO Product

Table 95. MicroNano Biologics Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)

Table 96. MicroNano Biologics Recent Development

Table 97. Precigenome Company Details

Table 98. Precigenome Business Overview

Table 99. Precigenome Lipid Nanoparticle CDMO Product

Table 100. Precigenome Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)

Table 101. Precigenome Recent Development

Table 102. Evonik Company Details

Table 103. Evonik Business Overview

Table 104. Evonik Lipid Nanoparticle CDMO Product

Table 105. Evonik Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)

Table 106. Evonik Recent Development

Table 107. Avanti Polar Lipids Company Details

Table 108. Avanti Polar Lipids Business Overview

Table 109. Avanti Polar Lipids Lipid Nanoparticle CDMO Product

Table 110. Avanti Polar Lipids Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)

Table 111. Avanti Polar Lipids Recent Development

Table 112. Genevant Sciences Company Details

Table 113. Genevant Sciences Business Overview

Table 114. Genevant Sciences Lipid Nanoparticle CDMO Product

Table 115. Genevant Sciences Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)

Table 116. Genevant Sciences Recent Development

Table 117. Nippon Fine Chemical Company Details

Table 118. Nippon Fine Chemical Business Overview

Table 119. Nippon Fine Chemical Lipid Nanoparticle CDMO Product

Table 120. Nippon Fine Chemical Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)

Table 121. Nippon Fine Chemical Recent Development

Table 122. Lipoid Company Details

Table 123. Lipoid Business Overview

Table 124. Lipoid Lipid Nanoparticle CDMO Product

Table 125. Lipoid Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)

Table 126. Lipoid Recent Development

Table 127. Research Programs/Design for This Report

Table 128. Key Data Information from Secondary Sources

Table 129. Key Data Information from Primary Sources

Table 130. Authors List of This Report

List of Figures

Figure 1. Lipid Nanoparticle CDMO Picture

Figure 2. Global Lipid Nanoparticle CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Lipid Nanoparticle CDMO Market Share by Type: 2024 VS 2031

Figure 4. Solid Lipid Nanoparticles Features

Figure 5. Nanostructured Lipid Carriers Features

Figure 6. Cationic Lipid-Nucleic Acid Complexes Features

Figure 7. Global Lipid Nanoparticle CDMO Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Lipid Nanoparticle CDMO Market Share by Application: 2024 VS 2031

Figure 9. Gene Therapy Case Studies

Figure 10. Vaccine Development Case Studies

Figure 11. Cancer Treatment Case Studies

Figure 12. Lipid Nanoparticle CDMO Report Years Considered

Figure 13. Global Lipid Nanoparticle CDMO Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Lipid Nanoparticle CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Lipid Nanoparticle CDMO Market Share by Region: 2024 VS 2031

Figure 16. Global Lipid Nanoparticle CDMO Market Share by Players in 2024

Figure 17. Global Lipid Nanoparticle CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Lipid Nanoparticle CDMO Revenue in 2024

Figure 19. North America Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Lipid Nanoparticle CDMO Market Share by Country (2020-2031)

Figure 21. United States Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Lipid Nanoparticle CDMO Market Share by Country (2020-2031)

Figure 25. Germany Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Lipid Nanoparticle CDMO Market Share by Region (2020-2031)

Figure 33. China Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Lipid Nanoparticle CDMO Market Share by Country (2020-2031)

Figure 41. Mexico Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Lipid Nanoparticle CDMO Market Share by Country (2020-2031)

Figure 45. Turkey Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. GenScript Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)

Figure 49. Creative Biolabs Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)

Figure 50. Merck Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)

Figure 51. Cytiva Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)

Figure 52. WuXi STA Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)

Figure 53. Carcell Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)

Figure 54. Croda International Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)

Figure 55. Detai Biotechnology Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)

Figure 56. Waters Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)

Figure 57. MicroNano Biologics Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)

Figure 58. Precigenome Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)

Figure 59. Evonik Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)

Figure 60. Avanti Polar Lipids Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)

Figure 61. Genevant Sciences Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)

Figure 62. Nippon Fine Chemical Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)

Figure 63. Lipoid Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Lipid Nanoparticle LNP Services Market Research Report 2025

Global Lipid Nanoparticle LNP Synthesis Services Market Research Report 2025

Global Lipid Nanoparticle LNP Production Equipment Market Research Report 2024

Global Lipid Contract Manufacturing Market Research Report 2024

Global Lipid Nanoparticle LNP Formulation Market Research Report 2024

Global LNP Synthesis System Market Research Report 2024

Global Lipid Nanoparticle LNP Formulation Service Market Research Report 2025

Global Lipid Nanoparticle LNP Development Service Market Research Report 2025

Global Oligonucleotide CDMO Market Research Report 2025

Global mRNA CDMO Service Market Research Report 2024

Global Lipid Nanoparticle Development Service Market Research Report 2024

Global Viral Vector Manufacturing CDMO Services Market Research Report 2024

Global Oligonucleotide Drug CDMO Services Market Research Report 2024

Global Lipid Nanoparticle LNP Raw Material Market Research Report 2024

Global Lipid Nanoparticles LNP Market Research Report 2024

Global Chemical CDMO Market Research Report 2024

Small Molecule Drug CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical CDMO Market Research Report 2025

Global Cell and Gene Therapy CDMO Services Market Research Report 2024

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6W17226

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Ecology Products Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29H6022

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Robotics Paint Booth Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3R7922

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34V19460

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions